Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01767818 · ClinicalTrials.gov registry record
Parkinson's Disease Biomarker Program
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 238
- Enrollment target
NCT01767818: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT01767818 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 238 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01767818 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 238 participants
- Enrollment target
Study Summary
The primary objective of this study is to obtain detailed clinical information and biologic specimens from subjects with PD toward the ultimate end of identifying a biomarker of PD. Because of the inherent difficulties of using clinical outcome measures to assess disease modification, the identification of biomarkers of PD is of paramount importance. The ideal PD biomarker would be one that is easily assayed in a convenient biological sample, varies proportionally with disease severity, is abnormal during the pre-symptomatic phase of the illness, and is unaffected by drugs or other interventions used to treat PD. The existence of a sensitive biomarker with these properties would enable much more effective disease modifying research that would likely be able to take advantage of smaller and potentially shorter trials.
Primary Outcome
This analysis will evaluate rates of progression in PD subjects and determine predictors of fast vs. slow progression
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 238 participants |
| Start Date | 2012-11 |
| Est. Completion | 2017-09-30 |
What the finished NCT01767818 record still lists
NCT01767818 is an observational study that tracks outcomes without assigning an intervention. The registered 238 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01767818 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01767818 about?
NCT01767818 is a clinical study titled "Parkinson's Disease Biomarker Program". The primary objective of this study is to obtain detailed clinical information and biologic specimens from subjects with PD toward the ultimate end of identifying a biomarker of PD. Because of the inherent difficulties of using clinical outcome measures to assess disease modification, the identifica...
What is the current status of trial NCT01767818?
This trial is currently completed. The enrollment target is 238 participants. The study started on 2012-11. Estimated completion is 2017-09-30.
Who is sponsoring clinical trial NCT01767818?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05012072 · 238 participants · NA
Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
- NCT05400252 · 238 participants · NA
Whole Health in VA Mental Health: Omnis Salutis
- NCT06380517 · 238 participants · Phase 3
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
- NCT06452797 · 238 participants · NA
Prognostic Estimates Among ICU Clinicians
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia